Interests

• Clinical Trials
• Large Dataset Analysis  
• Costing and Cost Effectiveness
• Policy Analysis
• Continuous Quality Improvement

Policy Analysis

We have a unique interest in understanding how new clinical and economic information may impact the healthcare system.  This includes how new evidence may be used to improve on current practices and policies; how new evidence may impact coverage and reimbursement policy; and how these may impact treatment patterns and clinical outcomes.